Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$2.40 – $3.76
44% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $14.93B | $14.38B | $8.93B | $8.58B | $9.39B | $6.45B | $5.70B | $6.67B |
| Cost of revenue | $15.01B | $14.13B | $8.84B | $8.36B | $9.20B | $6.34B | $5.57B | $6.46B |
| Gross profit | −$84.0M | $253.3M | $95.2M | $224.4M | $192.0M | $109.8M | $134.6M | $202.6M |
| Gross margin | -0.6% | 1.8% | 1.1% | 2.6% | 2.0% | 1.7% | 2.4% | 3.0% |
| R&D | $214.7M | $157.6M | $172.4M | $106.4M | $74.5M | $57.1M | $50.0M | $77.3M |
| Operating income | −$648.8M | $31.9M | −$91.9M | $66.8M | $54.6M | −$73.4M | $8.5M | $55.0M |
| EBITDA | −$630.1M | $227.3M | $59.5M | $268.4M | $135.3M | $107.7M | $199.6M | $85.6M |
| Net income | −$857.1M | −$12.3M | −$173.9M | $56.3M | −$72.1M | −$120.7M | −$20.3M | $52.8M |
| Net margin | -5.7% | -0.1% | -1.9% | 0.7% | -0.8% | -1.9% | -0.4% | 0.8% |
| EPS (diluted) | -0.11 | -0.00 | -0.02 | 0.01 | -0.01 | -0.02 | -0.00 | 0.07 |
Annual figures · source: Financial Modeling Prep
FIH MOBILE LTD
No one on the platform currently holds FXCNF.
No tracked institution reports a position in FXCNF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-06-15 | $0.2700 | 2026-07-15 |
| Execution date | Ratio |
|---|---|
| 2025-05-20 | 1-for-10reverse |
No one on the platform has traded FXCNF yet.
| $1.4B |
| — |
| IDXAFIDEX Biometrics ASA | $0.89 | +0.00% | $69M | — |
| KYYWYKeywords Studios plc | $16.66 | +0.00% | $1.5B | — |
Source: Financial Modeling Prep · peers by sector/industry
Trading at 1.5× sales vs its 1.1× historical median P/S.
Fair value ≈ $2.25 · price $3.00 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.